456 |
Rebaudioside D purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside D) |
Pending |
455 |
Bifidobacterium breve M-16V |
Pending |
454 |
Bifidobacterium breve M-16V |
Pending |
453 |
Bifidobacterium breve M-16V |
Pending |
452 |
Enzyme modified steviol glycosides |
Pending |
451 |
Calcium ascorbate/calcium threonate |
Pending |
450 |
Chlorella protothecoides S106 flour with 40-70% lipid |
Pending |
449 |
Medium chain triglycerides |
Pending |
448 |
Enzyme modified steviol glycosides |
Pending |
447 |
Potato protein isolates |
Pending |
446 |
Red grape pomace extract |
Pending |
445 |
Bifidobacterium animalis subsp. lactis strains HN019, Bi-07, Bl-04 and B420 |
Pending |
444 |
Milk protein concentrate and milk protein isolate |
Pending |
443 |
Shrimp-derived chitosan |
Pending |
442 |
Volatile oil of mustard (white) |
Pending |
441 |
Sodium ferrous citrate |
Pending |
440 |
Lactobacillus reuteri NCIMB 30242 |
Pending |
439 |
Iron complex of tartaric acid |
At notifier's request, FDA ceased to evaluate the notice |
438 |
Plant stanol esters |
FDA has no questions |
437 |
Beta-glucans from oat bran |
FDA has no questions |
436 |
Enzyme-modified dextrins |
FDA has no questions |
435 |
Mixture of six bacterial monophages specific to Salmonella |
Pending |
434 |
Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris) |
At notifier's request, FDA ceased to evaluate the notice |
433 |
Poloxamer fatty acid esters |
At notifier's request, FDA ceased to evaluate the notice |
432 |
Lutein diacetate |
FDA has no questions; some uses may require a color additive listing |
431 |
Colostral whey protein concentrate |
At notifier's request, FDA ceased to evaluate the notice |
430 |
Sugar beet fiber |
Pending |
429 |
Lactobacillus casei strain Shirota |
FDA has no questions |
428 |
Asparaginase enzyme preparation from genetically modified Aspergillus niger |
FDA has no questions |
427 |
Corn hull fiber |
FDA has no questions |
426 |
Rice hull fiber |
At notifier's request, FDA ceased to evaluate the notice |
425 |
Canola oil (low erucic acid rapeseed oil) |
FDA has no questions |
424 |
C-c-phycocyanin-enriched water extract of the cyanobacterium Arthrospira maxima or Arthrospira platensis, (also known as Spirulina maxima or Spirulina platensis) |
FDA has no questions; some uses may require a color additive listing |
423 |
Cow's milk-derived lactoferrin |
At notifier's request, FDA ceased to evaluate the notice |
422 |
Modified baker's yeast Saccharomyces cerevisiae |
FDA has no questions |
421 |
Sucrose fatty acid esters |
FDA has no questions |
420 |
Calcium acid pyrophosphate |
FDA has no questions |
419 |
L-alpha-glycerylphosphorylcholine |
FDA has no questions |
418 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
417 |
Dried biomass of Arthrospira platensis also known as Spirulina platensis (spirulina) |
FDA has no questions |
416 |
Lutein diacetate |
At notifier's request, FDA ceased to evaluate the notice |
415 |
Heat-killed Propionibacterium freudenreichii ET-3 culture (powder) |
FDA has no questions |
414 |
L-lysine monohydrochloride |
FDA has no questions |
413 |
Beta glucans derived from Ganoderma lucidum mycelium |
FDA has no questions |
412 |
Chitin-glucan from Aspergillus niger |
FDA has no questions |
411 |
Egg yolk-derived phospholipids |
FDA has no questions |
410 |
Lactobacillus reuteri strain DSM 17938 |
FDA has no questions |
409 |
Lactobacillus reuteri strain NCIMB 30242 |
At notifier's request, FDA ceased to evaluate the notice |
408 |
Sulfuric acid and sodium sulfate |
FDA has no questions |
407 |
Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX) |
FDA has no questions |